Shandong Wit Dyne Health Co.,Ltd. (SZSE: 000915)
Health Care · Pharmaceuticals · CN
CN¥24.27
+1.97% today · -29.7% 1Y
Shandong Wit Dyne Health Co.,Ltd. (SZSE: 000915) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $846.15M and employs 1,719 people.
Over the last twelve months the share price has lost 29.7%, trading between 23.93 and 36.16.
Tweenvest scores Shandong Wit Dyne Health Co.,Ltd. across four factors: quality 86/100, value 54/100, growth 53/100, dividend 91/100. Its strongest factor is dividend.
000915 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $846.15M
- Revenue (TTM)
- $280.63M
- P/E
- 13.53
- EPS
- 1.79
- Dividend yield
- 10.30%
- Beta (5Y)
- 0.06
- 52-week high
- CN¥36.16
- 52-week low
- CN¥23.93
- Avg volume (3M)
- —
- Shares outstanding
- 234.33M
- Employees
- 1,719
- Next earnings
- —
About Shandong Wit Dyne Health Co.,Ltd.
Shandong Wit Dyne Health Co., Ltd., founded on June 26, 1993, and headquartered in Jinan, China, dedicates its operations to the investigation, creation, and manufacture of pharmaceuticals and health solutions tailored for children. The company offers a wide array of products, which include vitamin A and D drops, effervescent granules containing compound calcium carbonate, licorice zinc granules, iron dextran granules, and pediatric ibuprofen suppositories. Its offerings further extend to specialized medications such as azithromycin granules, dimercaptosuccinic acid capsules, rifaximin dry suspension, and oral rehydration salt powder.
- ISIN
- CNE000000Z28
- Founded
- 1993
- Listed since
- Jun 9, 1999
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.